The Effect of Daratumumab in Patients With Monoclonal Gammopathy of Renal Significance (MGRS) in Finland | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Effect of Daratumumab in Patients With Monoclonal Gammopathy of Renal Significance (MGRS) in Finland	Blood Protein Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, glomerulonephritis, hematologic disorder, immune system disorder, immunoproliferative disorder, kidney disorder, kidney failure, monoclonal gammopathy, nephritis, urinary system disorder	Recruiting	Phase 2	2026-09-16		NCT06889948

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Helsinki University Central Hospital	127
Janssen, L.P. - Investigator Initiated Studies Program	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Helsinki University Hospital	Helsinki	Finland	46